What's Happening?
Mick Farrell, CEO of Resmed, has been appointed as the new chair of AdvaMed's board of directors, set to begin his two-year term in January. AdvaMed is a leading medtech lobbying group, and Farrell's role
will involve spearheading policy and technology initiatives across the industry. His focus will be on patient-first innovation, digital transformation, and expanding global access to medical technology. Farrell has been with Resmed since 2013, a company known for its sleep apnea and respiratory products. He has been a member of AdvaMed's board since 2015 and has led the international board committee. His predecessor, GE HealthCare CEO Peter Arduini, focused on imaging, digital health, and AI, contributing to significant advancements in Medicare coverage for breakthrough devices.
Why It's Important?
Mick Farrell's appointment as chair of AdvaMed's board comes at a critical time for the medtech industry, which is increasingly focusing on digital health and AI. His leadership could drive significant policy changes that enhance the delivery and personalization of healthcare services. By advocating for policies that support care delivery from hospitals to homes, Farrell aims to make healthcare more accessible and tailored to individual needs. This could lead to broader adoption of innovative medical technologies, potentially improving patient outcomes and reducing healthcare costs. His focus on global access also suggests a push towards making advanced medical technologies available in underserved regions.
What's Next?
As Mick Farrell takes on his new role, he is expected to outline his strategic priorities for AdvaMed in the coming year. This may include initiatives to further integrate AI into healthcare, address tariff concerns, and expand Medicare coverage for breakthrough devices. The medtech industry will be closely watching how these priorities unfold, as they could influence regulatory policies and market dynamics. Stakeholders, including healthcare providers and technology developers, may need to adapt to new standards and opportunities arising from these initiatives.
